Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3057% above fair value
$105.80−0.01 (-0.01%)
Close on Nov 12, 2026Market cap $60.98BP/E 59.8Yield –
Edwards Lifesciences operating margin
Operating margin is operating income as a percentage of revenue.
Edwards Lifesciences's operating margin for the twelve months ending Sep 30, 2026 was 21.6%. For fiscal 2025 it was 20.8%, against 25.3% the year before. The highest annual figure on record is 33.6% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.8% | −4.5 |
| FY2024 | Dec 31, 2024 | 25.3% | −0.8 |
| FY2023 | Dec 31, 2023 | 26.1% | −7.4 |
| FY2022 | Dec 31, 2022 | 33.6% | +1.3 |
| FY2021 | Dec 31, 2021 | 32.3% | +11.8 |
| FY2020 | Dec 31, 2020 | 20.5% | −5.9 |
| FY2019 | Dec 31, 2019 | 26.4% | +6.3 |
| FY2018 | Dec 31, 2018 | 20.1% | −11.6 |
| FY2017 | Dec 31, 2017 | 31.7% | +6.4 |
| FY2016 | Dec 31, 2016 | 25.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 17.4% | −2.3 |
| Q2 FY2026 | Jun 30, 2026 | 29.5% | +2.6 |
| Q1 FY2026 | Mar 31, 2026 | 29.0% | +1.0 |
| Q4 FY2025 | Dec 31, 2025 | 9.6% | −12.9 |
| Q3 FY2025 | Sep 30, 2025 | 19.8% | −6.1 |
| Q2 FY2025 | Jun 30, 2025 | 26.8% | +0.1 |
| Q1 FY2025 | Mar 31, 2025 | 27.9% | +1.7 |
| Q4 FY2024 | Dec 31, 2024 | 22.6% | −4.8 |
| Q3 FY2024 | Sep 30, 2024 | 25.9% | −3.5 |
| Q2 FY2024 | Jun 30, 2024 | 26.8% | +6.2 |
| Q1 FY2024 | Mar 31, 2024 | 26.2% | −5.6 |
| Q4 FY2023 | Dec 31, 2023 | 27.4% | −18.6 |
| Q3 FY2023 | Sep 30, 2023 | 29.4% | −1.1 |
| Q2 FY2023 | Jun 30, 2023 | 20.6% | −12.8 |
| Q1 FY2023 | Mar 31, 2023 | 31.8% | −0.9 |
| Q4 FY2022 | Dec 31, 2022 | 46.0% | +17.8 |
| Q3 FY2022 | Sep 30, 2022 | 30.5% | +0.7 |
| Q2 FY2022 | Jun 30, 2022 | 33.4% | −6.0 |
| Q1 FY2022 | Mar 31, 2022 | 32.7% | +1.2 |
| Q4 FY2021 | Dec 31, 2021 | 28.2% | −1.3 |
| Q3 FY2021 | Sep 30, 2021 | 29.8% | −1.6 |
| Q2 FY2021 | Jun 30, 2021 | 39.4% | +57.7 |
| Q1 FY2021 | Mar 31, 2021 | 31.5% | −0.2 |
| Q4 FY2020 | Dec 31, 2020 | 29.5% | +3.0 |
| Q3 FY2020 | Sep 30, 2020 | 31.4% | +4.5 |
| Q2 FY2020 | Jun 30, 2020 | -18.3% | −43.0 |
| Q1 FY2020 | Mar 31, 2020 | 31.7% | +4.1 |
| Q4 FY2019 | Dec 31, 2019 | 26.5% | +27.0 |
| Q3 FY2019 | Sep 30, 2019 | 26.9% | −0.6 |
| Q2 FY2019 | Jun 30, 2019 | 24.6% | −2.1 |
| Q1 FY2019 | Mar 31, 2019 | 27.6% | −0.6 |
| Q4 FY2018 | Dec 31, 2018 | -0.5% | −38.4 |
| Q3 FY2018 | Sep 30, 2018 | 27.5% | +1.4 |
| Q2 FY2018 | Jun 30, 2018 | 26.7% | −1.9 |
| Q1 FY2018 | Mar 31, 2018 | 28.2% | −5.5 |
| Q4 FY2017 | Dec 31, 2017 | 37.8% | – |
| Q3 FY2017 | Sep 30, 2017 | 26.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 28.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 33.8% | – |
See a number that looks wrong?